These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3548568)

  • 1. [Agranulocytosis caused by captopril].
    Assyag P; Koenig A; Fass H; Brechenmacher C
    Ann Cardiol Angeiol (Paris); 1987 Feb; 36(2):81-3. PubMed ID: 3548568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Agranulocytosis induced by captopril after 4 months of treatment].
    Fernández Seara J; Domínguez Alvarez LM; Rodríguez Pérez R; Pereira Jorge JA; Rodríguez Canal A
    An Med Interna; 1991 Aug; 8(8):398-400. PubMed ID: 1768752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Captopril-associated granulocytopenia in hypertension after renal transplantation.
    Shindo K; Matsuya F; Ura T; Jodai A; Shimomae H; Kuniyoshi M; Hirose T; Kusaba Y; Saito Y
    Clin Nephrol; 1984 Dec; 22(6):314-6. PubMed ID: 6396008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical experience with the angiotensin converting enzyme inhibitor captopril.
    Walter NM; Whitworth JA; Kincaid-Smith P
    Clin Exp Pharmacol Physiol Suppl; 1982; 7():117-21. PubMed ID: 6291829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Necrotizing blepharitis following captopril-induced agranulocytosis].
    Wizemann A
    Klin Monbl Augenheilkd; 1983 Jan; 182(1):82-5. PubMed ID: 6343707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Severe side-effects of captopril].
    Arcavi L; Estrov Z; Caspi A; Resnitzky P
    Harefuah; 1985 May; 108(9):439-41. PubMed ID: 3896985
    [No Abstract]   [Full Text] [Related]  

  • 7. [Side effects induced by captopril. Comparison of a series of hypertensive patients with renal failure and a series with cardiac failure].
    Kayanakis JG; Doat P; Grenet B; Albagnac N; Fauvel JM; Durand D; Suc JM; Bounhoure JP
    Arch Mal Coeur Vaiss; 1983 Sep; 76(9):1065-71. PubMed ID: 6227300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Agranulocytosis caused by captopril: report of a case].
    Ochoa Gómez FJ; Andrés Nilsson C; Salcedo Aguilar J; Campo Hernández JM; Peña Somovilla JL; Márquez de Prado M
    An Med Interna; 1989 Feb; 6(2):109-10. PubMed ID: 2491070
    [No Abstract]   [Full Text] [Related]  

  • 9. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin I-converting enzyme inhibition after renal transplantation.
    Grönhagen-Riska C; Fyhrquist F; Ahonen J; von Willebrand E; Häyry P
    Scand J Urol Nephrol Suppl; 1984; 79():63-7. PubMed ID: 6089320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Captopril-induced agranulocytosis: a case report.
    Young TH; Lin SH; Ko WS; Hwang WS; Ding YA
    Zhonghua Yi Xue Za Zhi (Taipei); 1993 Feb; 51(2):151-3. PubMed ID: 8385557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of severe resistant arterial hypertension with captopril. 58 patients, including 38 treated for more than 6 months (author's transl)].
    Zech PY; Trotta P; Labeeuw M
    Nouv Presse Med; 1981 Apr; 10(19):1571-4. PubMed ID: 7025847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angioneurotic edema, agranulocytosis, and fatal septicemia following captopril therapy.
    Suarez M; Ho PW; Johnson ES; Perez G
    Am J Med; 1986 Aug; 81(2):336-8. PubMed ID: 3526889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Captopril-induced toxic epidermal necrolysis and agranulocytosis successfully treated with granulocyte colony-stimulating factor.
    Winfred RI; Nanda S; Horvath G; Elnicki M
    South Med J; 1999 Sep; 92(9):918-20. PubMed ID: 10498172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Side effects of angiotensin converting enzyme inhibitor (captopril) in newborns and young infants.
    Gantenbein MH; Bauersfeld U; Baenziger O; Frey B; Neuhaus T; Sennhauser F; Bernet V
    J Perinat Med; 2008; 36(5):448-52. PubMed ID: 18605972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Converting-enzyme inhibitor therapy for chronic heart failure.
    Massie BM; Kramer BL; Topic N
    Herz; 1983 Apr; 8(2):71-80. PubMed ID: 6343210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of severe arterial hypertension with captopril (SQ 14.225) (author's transl)].
    Di Giulio S; Perez-Ramirez JL; Jamoun P; Grünfeld JP; Meyer P
    Nouv Presse Med; 1981 Apr; 10(19):1551-5. PubMed ID: 6269557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemolytic anemia: a rare but potentially serious adverse effect of captopril.
    Trimble MA; Sketch MH; Mehta RH
    Herz; 2007 Feb; 32(1):62-4. PubMed ID: 17323037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Agranulocytosis induced by captopril].
    Gómez-Martino Arroyo JR; Jorquera Plaza F; Ordóñez González R; Granda Rodríguez M
    An Med Interna; 1989 Jul; 6(7):387-8. PubMed ID: 2491496
    [No Abstract]   [Full Text] [Related]  

  • 20. [Captopril-induced agranulocytosis].
    López Aldeguer J; Catalá J; Sanz MA
    Med Clin (Barc); 1988 Feb; 90(5):218-9. PubMed ID: 3280900
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.